John Maraganore

  • Co-CEO of Corsera Health

  • Founding CEO of Alnylam Pharmaceuticals, where he helped pioneer RNAi therapeutics and led the company through global approvals and commercialization of its first four RNAi medicines

  • Drove Alnylam’s market capitalization beyond $25B and forged more than 20 major pharmaceutical alliances

  • Former Senior Vice President of Strategic Product Development
    at Millennium Pharmaceuticals

  • M.S. and Ph.D. from the University of Chicago